Preclinical 11C-Acetate-PET in multiple myeloma

Purpose:We hypothesized that in multiple myeloma cells (MMC), high membrane biosynthesis will induce acetate uptake in vitro and in vivo. Here, we studied acetate metabolism and targeting in MMC in vitro and tested the efficacy of ¹¹C-acetate-PET (positron emission tomography) to detect and quantitatively image myeloma treatment response in vivo. Experimental Design:Acetate fate tracking using ¹³C-edited-¹H NMR (nuclear magnetic resonance) was performed to study in vitro acetate uptake and metabolism in MMC. Effects of pharmacological modulation of acetate uptake or acetate incorporation into lipids on MMC cell survival and viability were assessed. Preclinical mouse MM models of subcutaneous and bone tumors were evaluated using ¹¹C-acetate-PET/CT imaging and tissue biodistribution. Results:In vitro, NMR showed significant uptake of acetate by MMC, and acetate incorporation into intracellular metabolites and membrane lipids. Inhibition of lipid synthesis and acetate transport was toxic to MMC, while sparing resident bone cells or normal B cells. In vivo, ¹¹C-acetate uptake by PET imaging was significantly enhanced in subcutaneous and bone MMC tumors compared to unaffected bone or muscle tissue. Likewise, ¹¹C-acetate uptake was significantly reduced in MM tumors after treatment. Conclusions:Uptake of acetate from the extracellular environment was enhanced in MMC and was critical to cellular viability. ¹¹C-acetate-PET detected the presence of myeloma cells in vivo, including uptake in intramedullary bone disease. ¹¹C-acetate-PET also detected response to therapy in vivo. Our data suggested that acetate metabolism and incorporation into lipids was crucial to MM cell biology and that ¹¹C-acetate-PET is a promising imaging modality for MM.

from Cancer via ola Kala on Inoreader http://ift.tt/2auvcnD
via IFTTT